Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.
News Medical on MSN
Gut microbiome may be a central player in the body's response to cancer
A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed ...
Researchers in Sweden have identified an unexpected biological mechanism that could influence future cancer treatments. Scientists in Sweden have uncovered an unexpected anti-cancer effect from a ...
Gastric and esophageal cancers rank among the deadliest cancers Worldwide, due to their biological complexity, late diagnosis, and limited response to ...
A scientific study suggests that weight loss drugs could reduce the risk of several cancers associated with obesity.
Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, ...
Cancer research laboratory tests can now be done using micro-physiological systems mimicking human physiology, allowing ...
NCI-Led Study Shows Median PFS of 9.6 Months Results Presented at AACR Special Conference on Innovations in Prostate CancerPRINCETON, N.J., Jan.
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
A team of researchers at the Georgetown University Lombardi Comprehensive Cancer Center published new research exploring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results